Last week, President Donald Trump shocked pharmaceutical companies by signing three executive orders (EOs) that will influence drug prices in favor of consumers, according to the White House.
One of the EOs, which would revive a 2018 rule that was nixed following negotiations with pharmaceutical companies, included an invitation...CMS Rules
After the publication of the Outpatient Prospective Payment System (OPPS) on Friday, the Trump Administration is holding off on a controversial transparency rule that would require hospitals to publicly post all privately negotiated payer rates. The Centers for Medicare and Medicaid Services (CMS) has promised to issue a "forthcoming...